The Gene Editing (GE) platform provides cost effective services in all phases of CRISPR -Cas projects realization in cells lines, mouse and zebrafish. Our portfolio ranges from gene knockout to the generation of small specific changes (point mutation, epitope tagging, small specific insertions/deletions) to loss and gain of function studies (CRISPR inhibition, CRISPR activation).
